The deal has a value of up to $330 million, with the final price tied to future sales of Optinose's flagship product.

CureDuchenne Ventures announced an initial $1M investment in Entos Pharmaceuticals Inc (Entos), a biotech company that develops genetic medicines utilizing its non-viral, redosable Fusogenix PLV ...

Despite hundreds of closures in the U.S., Subway ended 2024 with its second straight year of positive global net restaurant ...

CHICAGO, May 09, 2025 (GLOBE NEWSWIRE) -- The American Medical Association (AMA) named John J. Whyte, M.D., M.P.H., as its next ... "I am honored to join the AMA as CEO and serve all patients and ...

Dr. John Whyte has been tapped as the next CEO and executive vice president of the American Medical Association. Whyte, who specializes in internal medicine, will assume the role July 1 ...

John Mlynczak, President and CEO of the National Association of Music Merchants (NAMM), continues to voice his concern while advocating for the safeguarding of the industry. “The consensus is ...

With his severance package alone worth $69.3 million, more than the total pay packages disclosed for any other industry player, Bob Bakish, the former CEO of Paramount Global, was catapulted to ...

Alico, Inc. announced that its President and CEO, John Kiernan, will conduct one-on-one investor meetings at the BMO Global Farm to Market Conference in New York City on May 14-15, 2025.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

"This transaction reflects Subway's long-term growth potential, and the substantial value of our brand and our franchisees around the world," Subway CEO John Chidsey said at the time. The Source ...